Hims & Hers Health, Inc., doing business as hims, is an American telehealth company headquartered in San Francisco. It provides prescription medications, over-the-counter medications, and personal care products through a direct-to-consumer subscription model.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| HIMS | Hims & Hers Health, Inc. | 2026-07-16 15:46:39 | 33.8 | -3.34 | -8.99 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HIMS | 0001773751 | Hims & Hers Health, Inc. | US4330001060 | — | — | NYSE | 8011 | Services-Offices & Clinics of Doctors of Medicine | 1231 | DE | 2269 CHESTNUT ST | SAN FRANCISCO | CA | 94123 | UNITED STATES | US | 415-851-0195 | 2269 CHESTNUT ST, SAN FRANCISCO, CA, 94123 | 2269 CHESTNUT ST, SAN FRANCISCO, CA, 94123 | Oaktree Acquisition Corp. | Online pharmacy | 2017 | Andrew Dudum | 2,442 | https://hims.com | 10,100,000,000 | 0 | — | Hims & Hers Health, Inc., doing business as hims, is an American telehealth company headquartered in San Francisco. It provides prescription medications, over-the-counter medications, and personal care products through a direct-to-consumer subscription model. | 2026-07-16 16:06:06 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 10,100,000,000 | 6,200,000,000 | 158.9744 | — | — | — |
| 2024 | 3,900,000,000 | 2,100,000,000 | 116.6667 | — | — | — |
| 2023 | 1,800,000,000 | 960,000,000 | 114.2857 | — | — | — |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Mr. Elshenawy | Chief Technology Officer | 2025 | 375,000 | 3,000,000 | 57,216,276 | 278,470 | 0 | 60,869,746 |
| Mr. Chi | Chief Operating Officer | 2025 | 485,000 | 0 | 6,898,799 | 340,914 | 3,000 | 7,727,713 |
| Mr. Dudum | Chairman, Chief Executive Officer | 2025 | 494,792 | 0 | 10,635,352 | 585,763 | 243,000 | 22,958,907 |
| Mr. Okupe | Chief Financial Officer | 2025 | 530,875 | 0 | 7,473,689 | 376,763 | 17,481 | 8,398,808 |
| Ms. Boughton | Chief Legal Officer | 2025 | 464,375 | 0 | 4,024,269 | 305,065 | 3,000 | 4,796,709 |
| Fiscal Year | Employee Count |
|---|---|
| 2019 | 4 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 2,347,637,000 | 1,476,514,000 | 872,000,000 |
| Cost Of Revenue | 614,259,000 | 303,379,000 | 157,051,000 |
| Gross Profit | 1,733,378,000 | 1,173,135,000 | 714,949,000 |
| Research And Development Expenses | 149,301,000 | 78,819,000 | 48,227,000 |
| General And Administrative Expenses | 272,724,000 | 167,767,000 | 129,883,000 |
| Operating Expenses | 1,627,765,000 | 1,111,232,000 | 744,402,000 |
| Operating Income | 105,613,000 | 61,903,000 | -29,453,000 |
| Net Income | 128,365,000 | 126,038,000 | -23,546,000 |
| Earnings Per Share Basic | 0.57 | 0.58 | -0.11 |
| Earnings Per Share Diluted | 0.51 | 0.53 | -0.11 |
| Weighted Average Shares Outstanding Basic | 224,959,268 | 215,939,037 | 209,344,712 |
| Weighted Average Shares Outstanding Diluted | 258,230,547 | 236,808,876 | 209,344,712 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 228,616,000 | 220,584,000 | 96,663,000 |
| Marketable Securities Current | 348,876,000 | 79,667,000 | 124,318,000 |
| Accounts Receivable | 32,100,000 | 6,100,000 | 6,700,000 |
| Inventories | 80,128,000 | 64,427,000 | 22,464,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 4,374,000 | 8,901,000 | 5,238,000 |
| Total Assets Current | 767,638,000 | 395,831,000 | 265,053,000 |
| Marketable Securities Non Current | 351,263,000 | — | — |
| Property Plant And Equipment | — | — | — |
| Other Assets Non Current | 29,680,000 | 147,000 | 91,000 |
| Total Assets Non Current | 1,387,067,000 | 311,708,000 | 176,133,000 |
| Total Assets | 2,154,705,000 | 707,539,000 | 441,186,000 |
| Accounts Payable | 143,278,000 | 91,180,000 | 43,070,000 |
| Deferred Revenue | 127,160,000 | 75,300,000 | 7,733,000 |
| Short Term Debt | — | — | — |
| Other Liabilities Current | 78,518,000 | 53,013,000 | 28,972,000 |
| Total Liabilities Current | 404,431,000 | 221,367,000 | 88,468,000 |
| Long Term Debt | 972,580,000 | — | — |
| Other Liabilities Non Current | 11,734,000 | 0 | 22,000 |
| Total Liabilities Non Current | 1,209,346,000 | 9,456,000 | 8,689,000 |
| Total Liabilities | 1,613,777,000 | 230,823,000 | 97,157,000 |
| Common Stock | 23,000 | 22,000 | 21,000 |
| Retained Earnings | -113,772,000 | -242,137,000 | -368,175,000 |
| Accumulated Other Comprehensive Income | 2,294,000 | -324,000 | -124,000 |
| Total Shareholders Equity | 540,928,000 | 476,716,000 | 344,029,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 54,502,000 | 17,088,000 | 9,515,000 |
| Share Based Compensation Expense | 135,244,000 | 92,322,000 | 66,080,000 |
| Other Non Cash Income Expense | 2,135,000 | -357,000 | -195,000 |
| Change In Accounts Receivable | — | — | — |
| Change In Inventories | 13,722,000 | 41,612,000 | 902,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | 518,000 | 56,000 | 58,000 |
| Change In Accounts Payable | 30,297,000 | 43,710,000 | 7,324,000 |
| Change In Other Liabilities | -43,053,000 | 23,791,000 | 16,524,000 |
| Cash From Operating Activities | 300,006,000 | 251,084,000 | 73,483,000 |
| Purchases Of Marketable Securities | 725,838,000 | 160,564,000 | 157,239,000 |
| Sales Of Marketable Securities | 0 | 725,000 | 1,574,000 |
| Acquisition Of Property Plant And Equipment | 242,600,000 | 52,800,000 | — |
| Acquisition Of Business | 145,227,000 | 15,399,000 | 0 |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -1,024,958,000 | -19,048,000 | -12,106,000 |
| Tax Withholding For Share Based Compensation | 116,669,000 | 52,501,000 | 14,096,000 |
| Payments Of Dividends | 0 | 0 | 0 |
| Issuance Of Common Stock | 6,440,000 | 3,901,000 | 2,298,000 |
| Repurchase Of Common Stock | 89,960,000 | 83,039,000 | 1,999,000 |
| Issuance Of Long Term Debt | 970,000,000 | — | — |
| Repayment Of Long Term Debt | — | — | — |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | 729,620,000 | -107,845,000 | -11,475,000 |
| Change In Cash | 7,176,000 | 123,921,000 | 49,891,000 |
| Cash At End Of Period | 228,616,000 | 220,584,000 | 96,663,000 |
| Income Taxes Paid | 23,162,000 | 7,916,000 | 1,109,000 |
| Interest Paid | — | — | — |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | 0.57 | 0.58 | -0.11 |
| Price To Earnings Ratio | 56.9649 | 41.6897 | -80.9091 |
| Earnings Growth Rate | -1.7241 | -627.2727 | -65.625 |
| Price Earnings To Growth Ratio | -33.0396 | -0.0665 | 1.2329 |
| Book Value Per Share | 2.4046 | 2.2076 | 1.6434 |
| Price To Book Ratio | 13.5035 | 10.9529 | 5.4157 |
| Ebitda | 206,029,000 | 151,042,000 | -12,922,000 |
| Enterprise Value | 8,048,391,431.96 | — | — |
| Dividend Yield | 0 | 0 | 0 |
| Dividend Payout Ratio | 0 | 0 | 0 |
| Debt To Equity Ratio | 1.798 | — | — |
| Capital Expenditures | — | — | — |
| Free Cash Flow | — | — | — |
| Return On Equity | 0.2373 | 0.2644 | -0.0684 |
| One Year Beta | 2.1697 | 2.1716 | 1.6311 |
| Three Year Beta | 2.0225 | 1.6952 | 1.6093 |
| Five Year Beta | 1.8085 | 0.8629 | 0.7548 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Okupe Oluyemi | Chief Financial Officer | 2026-07-06 | 7,163 | A | 291,484 |
| Okupe Oluyemi | Chief Financial Officer | 2026-07-06 | 7,163 | D | 284,321 |
| Okupe Oluyemi | Chief Financial Officer | 2026-07-06 | 7,163 | D | 102,361 |
| Okupe Oluyemi | Chief Financial Officer | 2026-06-22 | 6,376 | A | 302,518 |
| Okupe Oluyemi | Chief Financial Officer | 2026-06-22 | 18,197 | D | 284,321 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Lisa McClain | 2025-09-12 | MI09 | Purchase | 2025-08-04 | Spouse | $1,001 - $15,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Capital Advisors, Ltd. LLC | 2026-06-30 | 2,000 | 54 | 37.037 |
| Crossmark Global Holdings, Inc. | 2026-06-30 | 424,881 | 12,255 | 34.67 |
| Sava Infond d.o.o. | 2026-06-30 | 762,740 | 22,000 | 34.67 |
| YOUSIF CAPITAL MANAGEMENT, LLC | 2026-06-30 | 2,073,197 | 59,798 | 34.67 |
| Prospera Financial Services Inc | 2026-06-30 | 755,804 | 21,801 | 34.6683 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| Global X Funds | 2026-04-30 | Global X Russell 2000 ETF | RSSL | 88,868 | 2,414,543.56 | 0.1692 |
| Pacer Funds Trust | 2026-04-30 | Pacer Trendpilot US Mid Cap ETF | PTMC | 23,932 | 650,232.44 | 0.1657 |
| Dimensional ETF Trust | 2026-04-30 | Dimensional U.S. Small Cap ETF | DFAS | 110,681 | 3,007,202.77 | 0.0214 |
| Direxion Shares ETF Trust | 2026-04-30 | Direxion Daily Mid Cap Bull 3X ETF | MIDU | 3,449 | 93,709.33 | 0.1121 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 2026-04-30 | Invesco RAFI US 1500 Small-Mid ETF | PRFZ | 39,761 | 1,080,306.37 | 0.0375 |